Enliven Therapeutics, Inc. (ELVN)
NASDAQ·Healthcare·Biotechnology
$59.41
+2.36%
Mkt Cap $3.77B
Analyst Ratings
Buy
8
Hold
0
Sell
0
Price Target (12 analysts)
$69.20
Range $59.00 – $80.00
Implied Upside
+16.5%
Consensus $69.20 vs current $59.41
NASDAQ·Healthcare·Biotechnology
$59.41
+2.36%
Mkt Cap $3.77B
Buy
8
Hold
0
Sell
0
Price Target (12 analysts)
$69.20
Range $59.00 – $80.00
+16.5%
Consensus $69.20 vs current $59.41